A real-world analysis of second-line treatment options in pancreatic cancer: liposomal-irinotecan plus 5-fluorouracil and folinic acid

BACKGROUND: Nanoliposomal irinotecan (nal-IRI) plus 5-fluorouracil/leucovorin (5-FU/LV) is a novel treatment option for gemcitabine-pretreated metastatic pancreatic adenocarcinoma (PAC) patients, but real-world evidence is rare. Our aim was to determine the effectiveness and tolerability of this reg...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Ther Adv Med Oncol
Glavni autori: Kieler, Markus, Unseld, Matthias, Bianconi, Daniela, Scheithauer, Werner, Prager, Gerald W.
Format: Artigo
Jezik:Inglês
Izdano: SAGE Publications 2019
Teme:
Original Research
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6640066/
https://ncbi.nlm.nih.gov/pubmed/31360237
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758835919853196
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items